LEMTRADA – Alemtuzumab uses, dose and side effects
LEMTRADA contains the active substance alemtuzumab used to treat a form of multiple sclerosis (MS) in adults, called relapsing-remitting multiple sclerosis (RRMS, relapsing remitting MS). LEMTRADA does not cure MS, but can reduce the number of relapses of MS. LEMTRADA can also help slow down or reverse certain signs and symptoms of MS. In clinical trials , patients treated with LEMTRADA had fewer relapses and were less likely to have impaired function compared with patients treated with a beta- interferon injected several times a week.
Read More